GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alumis Inc (NAS:ALMS) » Definitions » ROE % Adjusted to Book Value

ALMS (Alumis) ROE % Adjusted to Book Value : -75.96% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alumis ROE % Adjusted to Book Value?

Alumis's ROE % for the quarter that ended in Dec. 2024 was -124.58%. Alumis's PB Ratio for the quarter that ended in Dec. 2024 was 1.64. Alumis's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -75.96%.


Alumis ROE % Adjusted to Book Value Historical Data

The historical data trend for Alumis's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alumis ROE % Adjusted to Book Value Chart

Alumis Annual Data
Trend Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
- - -

Alumis Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only - - - - -75.96

Competitive Comparison of Alumis's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Alumis's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alumis's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alumis's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Alumis's ROE % Adjusted to Book Value falls into.



Alumis ROE % Adjusted to Book Value Calculation

Alumis's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / 1.64
=0.00%

Alumis's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-124.58% / 1.64
=-75.96%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alumis ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Alumis's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Alumis Business Description

Industry
Traded in Other Exchanges
N/A
Address
280 East Grand Avenue, South San Francisco, CA, USA, 94080
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.

Alumis Headlines

From GuruFocus